Response to letter to editor: "Knowing when and how to use epilepsy screening questionnaires"

Epilepsia. 2020 Apr;61(4):826-827. doi: 10.1111/epi.16463. Epub 2020 Mar 2.

Christopher B Eaton^{1

2}, Rhys H Thomas^{1

3}, Khalid Hamandi⁴, Gareth C Payne⁵, Michael P Kerr¹, David E J Linden^{1

6}, Michael J Owen¹, Adam C Cunningham¹, Ullrich Bartsch^{7

8}, Siske S Struik⁹, Marianne B M van den Bree¹

¹ Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK.
² Department of Child Life and Health, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
³ Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.
⁴ The Epilepsy Unit, University Hospital of Wales, Heath Park, Cardiff, UK.
⁵ Betsi Cadwaladr University Healthboard, Wales, UK.
⁶ Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.
⁷ School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
⁸ Lilly UK, Erl Wood Manor, Windlesham, UK.
⁹ Immunodeficiency Centre for Wales, University Hospital of Wales, Heath Park, Cardiff, UK.

No abstract available

Publication types